1-4 of 4
Chao Zhu, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Dose Reductions and Interruptions Due to Adverse Events (AEs) on Efficacy in Newly Diagnosed Chronic Myeloid Leukemia in ChronicPhase (CML-CP) Patients (pts) Receiving Either Dasatinib (D) or Imatinib(IM): Analysis of the DASISION Trial

Elias Jabbour, Hagop M Kantarjian, Alfonso Quintas-Cardama, Francois Guilhot, MD, Chao Zhu, PhD, Janet Hong, PharmD, Zachary Cain, PharmD, Jorge E. Cortes
Journal: Blood
Blood (2011) 118 (21): 2768.
https://doi.org/10.1182/blood.V118.21.2768.2768
Published: 2011
Journal Articles

Dasatinib Compared with Imatinib In Newly Diagnosed Chronic Myelogenous Leukemia In Chronic Phase (CML-CP):Results of Japanese Subset Analysis In DASISION Trial.

Michinori Ogura, MD, PhD, Hirohisa Nakamae, MD, PhD, Shin Fujisawa, MD, PhD, Kenichi Ishizawa, MD, Masafumi Taniwaki, MD, PhD, Atae Utsunomiya, MD, PhD, Kosei Matsue, MD, PhD, Kazuo Tamura, MD, Kensuke Usuki, MD, PhD, Mitsune Tanimoto, MD, PhD, Yoji Ishida, MD, PhD, Hideki Akiyama, MD, PhD, Rika Sakai, MD, PhD, Masanobu Kasai, MD, PhD, Masayuki Hino, MD, PhD, Kyoji Ueda, MD, PhD, Taku Seriu, MD, PhD, M. Brigid Bradley-Garelik, MD, Chao Zhu, PhD
Journal: Blood
Blood (2010) 116 (21): 4484.
https://doi.org/10.1182/blood.V116.21.4484.4484
Published: 2010
Journal Articles

Dasatinib Versus Imatinib In Patients with Newly Diagnosed Chronic Myeloid Leukemia In Chronic Phase (CML-CP) In the DASISION Trial: 18-Month Follow-up

Neil Shah, MD, Ph.D., Hagop Kantarjian, MD, Andreas Hochhaus, MD, Jorge E. Cortes, MD, M. Brigid Bradley-Garelik, MD, Chao Zhu, PhD, Michele Baccarani, MD
Journal: Blood
Blood (2010) 116 (21): 206.
https://doi.org/10.1182/blood.V116.21.206.206
Published: 2010
Journal Articles

Occurrence, Management, and Outcomes In Patients with Pleural Effusion During Dasatinib Treatment for Chronic-Phase Chronic Myeloid Leukemia (CML-CP) In the First-Line Setting: Analysis of the DASISION Trial

Kimmo Porkka, MD, PhD, Michele Baccarani, MD, Andreas Hochhaus, MD, Hagop Kantarjian, MD, Satu Mustjoki, MD, PhD, M. Brigid Bradley-Garelik, MD, Chao Zhu, PhD, Jorge E. Cortes, MD
Journal: Blood
Blood (2010) 116 (21): 2282.
https://doi.org/10.1182/blood.V116.21.2282.2282
Published: 2010